BIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
- Investigator
- Thomas J George
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
BIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the anti-PD-1 antibody pembrolizumab versus pembrolizumab (+ placebo in phase 3) as first-line…
This phase II ADC MATCH screening and multi-sub-study treatment trial is evaluating whether biomarker-directed treatment with one of three antibody-drug conjugates (ADCs) (sacituzumab govitecan, enfortumab vedotin, and trastuzumab deruxtecan) works…
October 8, 2025
GAINESVILLE, Fla. — A team of researchers led by a University of Florida Health scientist recommends the universal immunization of pregnant women and infants…
College of Pharmacy, +1 more
Muhammad J. Tariq, MD, was drawn to hematology and oncology by the rapidly evolving science and the opportunity to help patients live full lives. After…
A fluffy, long-necked cousin of the camel might be the key to protecting against SARS-like viruses. Yes, you heard that correctly. In a new study from researchers in Belgium, a team discovered a...
Your next blood glucose meter reading could be a lot more revealing. In addition to confirming blood sugar levels, it might also determine the level of antibodies that protect against...